Home / Resources
Biosimilars Council works to ensure a positive environment for patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/0jAeG0TOPj
If the entire Affordable Care Act (#ACA) is overturned as unconstitutional, it could eliminate the Biologics Price Competition and Innovation Act (#BPCIA) and threaten the accessibility of life-saving treatments in the U.S. Read more: https://www.washingtonpost.com/opinions/letters-to-the-editor/striking-down-obamacare-would-also-nix-generic-biologic-drugs/2020/06/28/44a4a630-b7c4-11ea-9a1d-d3db1cbe07ce_story.html
601 New Jersey Ave NW, Suite 850 Washington DC 20001
Sign up for our Newsletter
©2020 Biosimilars Council
Biosimilars Council is a division of the Association for Accessible Medicines.
Sign up for Biosimilars Council Newsletter to hear about the field, learn about events, and find out how you can make an impact.
Never see this message again.